Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats

BACKGROUND: Treatment with metformin, the biguanide of hepatic insulin sensitizer, in patients with non-alcoholic fatty liver disease (NAFLD) has been reported with contradictory findings regarding the effectiveness on blood lipids and liver histology. In this study, we aimed to explore the preventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Yi, Kong, Xianhe, Fan, Rongrong, Ye, Yanbin, Mai, Haiyan, Zhuo, Shuyu, Lu, Wei, Ruan, Peishan, Fang, Shi, Yang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852932/
https://www.ncbi.nlm.nih.gov/pubmed/31749893
http://dx.doi.org/10.1186/s13098-019-0491-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852932/
https://www.ncbi.nlm.nih.gov/pubmed/31749893
http://dx.doi.org/10.1186/s13098-019-0491-1

Ejemplares similares